Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, ...

The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...

Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

The first three factors come into play during weight loss ... Those who experience hair loss while taking semaglutide drugs should consult with a dermatologist to determine whether it’s due ...

Adding an anti-obesity medication alongside behavioral therapy produced significantly more weight loss in patients who ...